REGADENOSON ANHYDROUS
UNII 7AXV542LZ4

Substance Identification & Data

This profile provides standardized clinical and technical data for Regadenoson Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7AXV542LZ4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 313348-27-5 and the RxNorm Concept ID (RxCUI) 1546015. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7AXV542LZ4

CAS Registry Number

313348-27-5

RxNorm Concept ID

1546015

Detailed Substance Profile

Preferred Name

REGADENOSON ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

7AXV542LZ4

The specific atomic composition represented as a molecular structure string.

InChIKey

C15H18N8O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LZPZPHGJDAGEJZ-AKAIJSEGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171933

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

219024

Unique identification number in the NCBI database of chemical substances.

INN ID

8488

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1(O[C@@H]([C@H]([C@H]1O)O)CO)n2c3nc(-n4cc(cn4)C(=O)NC)nc(c3nc2)N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Regadenoson Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.